Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

17beta-Estradiol modulates apoptosis in pancreatic beta-cells by specific involvement of the sulfonylurea receptor (SUR) isoform SUR1.

Ackermann S, Hiller S, Osswald H, Lösle M, Grenz A, Hambrock A.

J Biol Chem. 2009 Feb 20;284(8):4905-13. doi: 10.1074/jbc.M807638200. Epub 2008 Dec 18.

2.

Resveratrol binds to the sulfonylurea receptor (SUR) and induces apoptosis in a SUR subtype-specific manner.

Hambrock A, de Oliveira Franz CB, Hiller S, Grenz A, Ackermann S, Schulze DU, Drews G, Osswald H.

J Biol Chem. 2007 Feb 2;282(5):3347-56. Epub 2006 Nov 30.

3.

Glibenclamide-induced apoptosis is specifically enhanced by expression of the sulfonylurea receptor isoform SUR1 but not by expression of SUR2B or the mutant SUR1(M1289T).

Hambrock A, de Oliveira Franz CB, Hiller S, Osswald H.

J Pharmacol Exp Ther. 2006 Mar;316(3):1031-7. Epub 2005 Nov 23.

PMID:
16306272
4.

The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2.

Stephan D, Stauss E, Lange U, Felsch H, Löffler-Walz C, Hambrock A, Russ U, Quast U.

Br J Pharmacol. 2005 Apr;144(8):1078-88.

5.
6.

Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.

Felsch H, Lange U, Hambrock A, Löffler-Walz C, Russ U, Carroll WA, Gopalakrishnan M, Quast U.

Br J Pharmacol. 2004 Apr;141(7):1098-105. Epub 2004 Mar 15.

7.

Binding and effect of K ATP channel openers in the absence of Mg2+.

Russ U, Lange U, Löffler-Walz C, Hambrock A, Quast U.

Br J Pharmacol. 2003 May;139(2):368-80.

8.

beta3-Adrenergic regulation of an ion channel in the heart-inhibition of the slow delayed rectifier potassium current I(Ks) in guinea pig ventricular myocytes.

Bosch RF, Schneck AC, Kiehn J, Zhang W, Hambrock A, Eigenberger BW, Rüb N, Gogel J, Mewis C, Seipel L, Kühlkamp V.

Cardiovasc Res. 2002 Dec;56(3):393-403.

PMID:
12445880
9.

Mg2+ sensitizes KATP channels to inhibition by DIDS: dependence on the sulphonylurea receptor subunit.

Gojkovic-Bukarica L, Hambrock A, Löffler-Walz C, Quast U, Russ U.

Br J Pharmacol. 2002 Oct;137(4):429-40.

10.

The stereoenantiomers of a pinacidil analog open or close cloned ATP-sensitive K+ channels.

Lange U, Löffler-Walz C, Englert HC, Hambrock A, Russ U, Quast U.

J Biol Chem. 2002 Oct 25;277(43):40196-205. Epub 2002 Aug 8.

11.

Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotides.

Hambrock A, Löffler-Walz C, Quast U.

Br J Pharmacol. 2002 Aug;136(7):995-1004.

12.

Four novel splice variants of sulfonylurea receptor 1.

Hambrock A, Preisig-Müller R, Russ U, Piehl A, Hanley PJ, Ray J, Daut J, Quast U, Derst C.

Am J Physiol Cell Physiol. 2002 Aug;283(2):C587-98.

13.
14.

Interaction of the sulfonylthiourea HMR 1833 with sulfonylurea receptors and recombinant ATP-sensitive K(+) channels: comparison with glibenclamide.

Russ U, Lange U, Löffler-Walz C, Hambrock A, Quast U.

J Pharmacol Exp Ther. 2001 Dec;299(3):1049-55.

PMID:
11714894
15.
16.

Synthesis and characterization of a novel tritiated KATP channel opener with a benzopyran structure.

Manley PW, Löffler-Walz C, Russ U, Hambrock A, Moenius T, Quast U.

Br J Pharmacol. 2001 May;133(2):275-85.

17.

Coexpression with the inward rectifier K(+) channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide.

Russ U, Hambrock A, Artunc F, Löffler-Walz C, Horio Y, Kurachi Y, Quast U.

Mol Pharmacol. 1999 Nov;56(5):955-61.

PMID:
10531400
18.

ATP-Sensitive K+ channel modulator binding to sulfonylurea receptors SUR2A and SUR2B: opposite effects of MgADP.

Hambrock A, Löffler-Walz C, Kloor D, Delabar U, Horio Y, Kurachi Y, Quast U.

Mol Pharmacol. 1999 May;55(5):832-40.

PMID:
10220561
19.

Mg2+ and ATP dependence of K(ATP) channel modulator binding to the recombinant sulphonylurea receptor, SUR2B.

Hambrock A, Löffler-Walz C, Kurachi Y, Quast U.

Br J Pharmacol. 1998 Oct;125(3):577-83.

20.

Binding and effects of KATP channel openers in the vascular smooth muscle cell line, A10.

Russ U, Metzger F, Kickenweiz E, Hambrock A, Krippeit-Drews P, Quast U.

Br J Pharmacol. 1997 Nov;122(6):1119-26.

Supplemental Content

Loading ...
Support Center